MG53 protein shown to be useful for treating traumatic tissue damage

June 21, 2012, University of Medicine and Dentistry of New Jersey

Throughout the lifecycle, injury to the body’s cells occurs naturally, as well as through trauma. Cells have the ability to repair and regenerate themselves, but a defect in the repair process can lead to cardiovascular, neurological, muscular or pulmonary diseases. Recent discoveries of key genes that control cell repair have advanced the often painstaking search for ways to enhance the repair process.

A new study by researchers from the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School reports that the protein MG53, previously shown to be the key initiator in the cell membrane , has the potential to be used directly as a therapeutic approach to treating traumatic . The research, published today, is featured on the cover of Science Translational Medicine.

“We studied the use of MG53 in treating muscular dystrophy by targeting the protein directly to the damaged muscle. The direct application of MG53 slowed the development of the disease by repairing damaged muscle membranes,” said Noah Weisleder, PhD, assistant professor of physiology and biophysics and corresponding author of the study. “Our findings also suggest that MG53 could be used in regenerative medicine to treat other human diseases in which traumatic cell injury occurs.”

The study established methods to produce MG53 protein for use as a drug in different formulations that were effective when applied both inside and outside of damaged cells. Evidence showed that MG53 initiated repair to cell membranes in striated muscles, where it occurs naturally, but also initiated repair mechanisms outside of the muscle cells, providing protection to the tissue and slowing progression of disease. Additional research as part of this study found that the application of the protein as a therapy is safe.

MG53 was discovered in 2008 by Jianjie Ma, PhD, professor and acting chair of physiology and biophysics at UMDNJ-Robert Wood Johnson Medical School, who was the first to specifically pinpoint that the protein was responsible for promoting cell repair.

“We believe this new research could translate into therapeutic treatment for a broad range of diseases, including heart attack, lung injury and kidney disease, as well as muscular dystrophy,” said Dr. Ma, who oversaw this study. “Before clinical trials can begin, we must complete the pre-clinical studies that include additional safety tests and production of MG53 protein that can be used in human patients as a therapeutic drug.”

The study was conducted in conjunction with TRIM-edicine, a privately held biotechnology company spun-off from UMDNJ and created to commercialize the development of novel biopharmaceutical products in which Dr. Ma and Dr. Weisleder hold an interest. The research was funded by grants from the National Institutes of Health (NIH), an NIH Small Business Research Grant, and the Jain Foundation.

Explore further: Naturally produced protein could boost brain repair

Related Stories

Naturally produced protein could boost brain repair

January 10, 2012
(Medical Xpress) -- Scientists from the Medical Research Council (MRC) have discovered that a protein produced by blood vessels in the brain could be used to help the brain repair itself after injury or disease.

Stem cells, signaling pathways identified in lung repair

October 11, 2011
(Medical Xpress) -- Researchers at National Jewish Health have identified cells and signaling molecules that trigger the repair of injured lungs. Stijn De Langhe, PhD, and his colleagues report October 10, 2011, online in ...

Recommended for you

Stem-cell technology aids 3-D printed cartilage repair

April 20, 2018
Novel stem-cell technology developed at Swinburne will be used to grow the massive number of stem cells required for a new hand-held 3-D printer that will enable surgeons to create patient-specific bone and cartilage.

DOR protein deficiency favors the development of obesity

April 20, 2018
Obesity is a world health problem. Excessive accumulation of fat tissue (adipose tissue) increases the risk of cardiovascular disease, hypertension, diabetes and some types of cancer. However, some obese individuals are less ...

Defect in debilitating neurodegenerative disease reversed in mouse nerves

April 19, 2018
Scientists have developed a new drug compound that shows promise as a future treatment for Charcot-Marie-Tooth disease, an inherited, often painful neurodegenerative condition that affects nerves in the hands, arms, feet ...

Molecule that dilates blood vessels hints at new way to treat heart disease

April 19, 2018
Americans die of heart or cardiovascular disease at an alarming rate. In fact, heart attacks, strokes and related diseases will kill an estimated 610,000 Americans this year alone. Some medications help, but to better tackle ...

Team develops new approach to study long non-coding RNAs

April 19, 2018
Until recently, scientific research concentrated almost exclusively on the 2 percent of the genome's protein coding regions, virtually ignoring the other 98 percent - a vast universe of non-coding genetic material previously ...

Gene-edited stem cells show promise against HIV in non-human primates

April 19, 2018
Gene editing of bone marrow stem cells in pigtail macaques infected with simian/human immunodeficiency virus (SHIV) significantly reduces the size of dormant "viral reservoirs" that pose a risk of reactivation. Christopher ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.